Biosfer Teslab is a spin-off company from the Rovira i Virgili University (URV) and the Pere Virgili Institute for Health Research (IISPV) that focuses on developing in-vitro diagnostic tests utilizing NMR technology. Their flagship product, Liposcale, is already being commercialized in clinical practice. The company's scope spans beyond Liposcale to include services for metabolomics profiling of serum, urine, fecal, tissue, and cell culture. Their mission is to provide fluid and biological tissue analysis services using NMR and develop medical software to aid health professionals and the scientific community in studying, diagnosing, and treating metabolic disorders to advance knowledge and improve people's health.
Founded in 2014, Biosfer Teslab operates in the Information Technology sector with headquarters in Spain. Currently, there is no information available regarding their last investment or the involved investors.